These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 34743980)
1. Preventive and therapeutic role of betaine in liver disease: A review on molecular mechanisms. Wang C; Ma C; Gong L; Dai S; Li Y Eur J Pharmacol; 2021 Dec; 912():174604. PubMed ID: 34743980 [TBL] [Abstract][Full Text] [Related]
2. Betaine prevented fructose-induced NAFLD by regulating LXRα/PPARα pathway and alleviating ER stress in rats. Ge CX; Yu R; Xu MX; Li PQ; Fan CY; Li JM; Kong LD Eur J Pharmacol; 2016 Jan; 770():154-64. PubMed ID: 26593707 [TBL] [Abstract][Full Text] [Related]
3. n-3 Polyunsaturated fatty acids for the management of alcoholic liver disease: A critical review. Wang M; Ma LJ; Yang Y; Xiao Z; Wan JB Crit Rev Food Sci Nutr; 2019; 59(sup1):S116-S129. PubMed ID: 30580553 [TBL] [Abstract][Full Text] [Related]
4. Betaine inhibits toll-like receptor 4 expression in rats with ethanol-induced liver injury. Shi QZ; Wang LW; Zhang W; Gong ZJ World J Gastroenterol; 2010 Feb; 16(7):897-903. PubMed ID: 20143470 [TBL] [Abstract][Full Text] [Related]
5. Betaine modulates oxidative stress, inflammation, apoptosis, autophagy, and Akt/mTOR signaling in methionine-choline deficiency-induced fatty liver disease. Veskovic M; Mladenovic D; Milenkovic M; Tosic J; Borozan S; Gopcevic K; Labudovic-Borovic M; Dragutinovic V; Vucevic D; Jorgacevic B; Isakovic A; Trajkovic V; Radosavljevic T Eur J Pharmacol; 2019 Apr; 848():39-48. PubMed ID: 30689995 [TBL] [Abstract][Full Text] [Related]
6. Alleviation of alcoholic liver injury by betaine involves an enhancement of antioxidant defense via regulation of sulfur amino acid metabolism. Jung YS; Kim SJ; Kwon DY; Ahn CW; Kim YS; Choi DW; Kim YC Food Chem Toxicol; 2013 Dec; 62():292-8. PubMed ID: 23994088 [TBL] [Abstract][Full Text] [Related]
7. Protective effect and mechanism of Qiwei Tiexie capsule on 3T3-L1 adipocytes cells and rats with nonalcoholic fatty liver disease by regulating LXRα, PPARγ, and NF-κB-iNOS-NO signaling pathways. Suolang PC; Liu BQ; Chen J; De J; Nima ZB; Dunzhu CR J Ethnopharmacol; 2019 May; 236():316-325. PubMed ID: 30851372 [TBL] [Abstract][Full Text] [Related]
8. Molecular mechanisms and therapeutic implications of dihydromyricetin in liver disease. Chen J; Wang X; Xia T; Bi Y; Liu B; Fu J; Zhu R Biomed Pharmacother; 2021 Oct; 142():111927. PubMed ID: 34339914 [TBL] [Abstract][Full Text] [Related]
9. Research progress in use of traditional Chinese medicine monomer for treatment of non-alcoholic fatty liver disease. Zhou H; Ma C; Wang C; Gong L; Zhang Y; Li Y Eur J Pharmacol; 2021 May; 898():173976. PubMed ID: 33639194 [TBL] [Abstract][Full Text] [Related]
10. Betaine chemistry, roles, and potential use in liver disease. Day CR; Kempson SA Biochim Biophys Acta; 2016 Jun; 1860(6):1098-106. PubMed ID: 26850693 [TBL] [Abstract][Full Text] [Related]
11. Betaine protects against high-fat-diet-induced liver injury by inhibition of high-mobility group box 1 and Toll-like receptor 4 expression in rats. Zhang W; Wang LW; Wang LK; Li X; Zhang H; Luo LP; Song JC; Gong ZJ Dig Dis Sci; 2013 Nov; 58(11):3198-206. PubMed ID: 23861108 [TBL] [Abstract][Full Text] [Related]
12. Upregulation of Nrf2-related cytoprotective genes expression by acetaminophen-induced acute hepatotoxicity in mice and the protective role of betaine. Khodayar MJ; Kalantari H; Khorsandi L; Rashno M; Zeidooni L Hum Exp Toxicol; 2020 Jul; 39(7):948-959. PubMed ID: 32081044 [TBL] [Abstract][Full Text] [Related]
13. The Role of Oxidative Stress and Antioxidants in Liver Diseases. Li S; Tan HY; Wang N; Zhang ZJ; Lao L; Wong CW; Feng Y Int J Mol Sci; 2015 Nov; 16(11):26087-124. PubMed ID: 26540040 [TBL] [Abstract][Full Text] [Related]
14. Novel insights into the mechanisms whereby isoflavones protect against fatty liver disease. Qiu LX; Chen T World J Gastroenterol; 2015 Jan; 21(4):1099-107. PubMed ID: 25632182 [TBL] [Abstract][Full Text] [Related]
15. Betaine protects mice against acetaminophen hepatotoxicity possibly via mitochondrial complex II and glutathione availability. Khodayar MJ; Kalantari H; Khorsandi L; Rashno M; Zeidooni L Biomed Pharmacother; 2018 Jul; 103():1436-1445. PubMed ID: 29864928 [TBL] [Abstract][Full Text] [Related]
16. Effects of betaine on non-alcoholic liver disease. Chen W; Xu M; Xu M; Wang Y; Zou Q; Xie S; Wang L Nutr Res Rev; 2022 Jun; 35(1):28-38. PubMed ID: 33818349 [TBL] [Abstract][Full Text] [Related]
20. Adverse signaling of scavenger receptor class B1 and PGC1s in alcoholic hepatosteatosis and steatohepatitis and protection by betaine in rat. Varatharajalu R; Garige M; Leckey LC; Arellanes-Robledo J; Reyes-Gordillo K; Shah R; Lakshman MR Am J Pathol; 2014 Jul; 184(7):2035-44. PubMed ID: 24814604 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]